1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Piazza, M. Futrega, K. Spratt, D.E. Guillemette, J.G. Dieckmann, T. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 51 3651 3661 10.1021/bi300327z 22486744 Structure and Dynamics of Calmodulin (CaM) Bound to Nitric Oxide Synthase Peptides: Effects of a Phosphomimetic CaM Mutation. 2012 10.2210/pdb2ll7/pdb pdb_00002ll7 16721.350 Calmodulin 1 man polymer 1838.195 Nitric oxide synthase, endothelial 1.14.13.39 Calmodulin-binding region residues 493-509 1 man polymer CaM Constitutive NOS, cNOS, EC-NOS, Endothelial NOS, eNOS, NOS type III, NOSIII no no ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTD SEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAK ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTD SEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAK A polypeptide(L) no no KKTFKEVANAVKISASL KKTFKEVANAVKISASL B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human sample CALM1, CALM, CAM, CAM1, CALM2, CAM2, CAMB, CALM3, CALML2, CAM3, CAMC, CAMIII 9606 Homo sapiens 562 Escherichia coli pET9dCaM human sample NOS3 9606 Homo sapiens 562 Escherichia coli database_2 pdbx_database_status repository Initial release Database references Other 1 0 2012-05-16 1 1 2023-06-14 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.status_code_nmr_data BMRB Y RCSB 2011-10-29 REL REL REL REL structures with the lowest energy 20 20 2D 1H-15N HSQC 3D CBCA(CO)NH 3D HNCA 3D HCCH-TOCSY 3D 1H-15N NOESY 3D 1H-13C NOESY aliphatic 1.0 mM [U-99% 13C; U-99% 15N] 1.0 mM 100 mM 10 mM 0.2 mM 6.0 ambient 298 K DGSA-distance geometry simulated annealing 1 lowest energy 1.0 mM [U-99% 13C; U-99% 15N] protein_1, 1.0 mM protein_2, 100 mM potassium chloride, 10 mM calcium chloride, 0.2 mM sodium azide, 90% H2O/10% D2O 90% H2O/10% D2O Brunger, Adams, Clore, Gros, Nilges and Read structure solution CNSSOLVE Brunger, Adams, Clore, Gros, Nilges and Read refinement CNSSOLVE 600 Bruker DRX Bruker DRX ALA 1 n 1 ALA 1 A ASP 2 n 2 ASP 2 A GLN 3 n 3 GLN 3 A LEU 4 n 4 LEU 4 A THR 5 n 5 THR 5 A GLU 6 n 6 GLU 6 A GLU 7 n 7 GLU 7 A GLN 8 n 8 GLN 8 A ILE 9 n 9 ILE 9 A ALA 10 n 10 ALA 10 A GLU 11 n 11 GLU 11 A PHE 12 n 12 PHE 12 A LYS 13 n 13 LYS 13 A GLU 14 n 14 GLU 14 A ALA 15 n 15 ALA 15 A PHE 16 n 16 PHE 16 A SER 17 n 17 SER 17 A LEU 18 n 18 LEU 18 A PHE 19 n 19 PHE 19 A ASP 20 n 20 ASP 20 A LYS 21 n 21 LYS 21 A ASP 22 n 22 ASP 22 A GLY 23 n 23 GLY 23 A ASP 24 n 24 ASP 24 A GLY 25 n 25 GLY 25 A THR 26 n 26 THR 26 A ILE 27 n 27 ILE 27 A THR 28 n 28 THR 28 A THR 29 n 29 THR 29 A LYS 30 n 30 LYS 30 A GLU 31 n 31 GLU 31 A LEU 32 n 32 LEU 32 A GLY 33 n 33 GLY 33 A THR 34 n 34 THR 34 A VAL 35 n 35 VAL 35 A MET 36 n 36 MET 36 A ARG 37 n 37 ARG 37 A SER 38 n 38 SER 38 A LEU 39 n 39 LEU 39 A GLY 40 n 40 GLY 40 A GLN 41 n 41 GLN 41 A ASN 42 n 42 ASN 42 A PRO 43 n 43 PRO 43 A THR 44 n 44 THR 44 A GLU 45 n 45 GLU 45 A ALA 46 n 46 ALA 46 A GLU 47 n 47 GLU 47 A LEU 48 n 48 LEU 48 A GLN 49 n 49 GLN 49 A ASP 50 n 50 ASP 50 A MET 51 n 51 MET 51 A ILE 52 n 52 ILE 52 A ASN 53 n 53 ASN 53 A GLU 54 n 54 GLU 54 A VAL 55 n 55 VAL 55 A ASP 56 n 56 ASP 56 A ALA 57 n 57 ALA 57 A ASP 58 n 58 ASP 58 A GLY 59 n 59 GLY 59 A ASN 60 n 60 ASN 60 A GLY 61 n 61 GLY 61 A THR 62 n 62 THR 62 A ILE 63 n 63 ILE 63 A ASP 64 n 64 ASP 64 A PHE 65 n 65 PHE 65 A PRO 66 n 66 PRO 66 A GLU 67 n 67 GLU 67 A PHE 68 n 68 PHE 68 A LEU 69 n 69 LEU 69 A THR 70 n 70 THR 70 A MET 71 n 71 MET 71 A MET 72 n 72 MET 72 A ALA 73 n 73 ALA 73 A ARG 74 n 74 ARG 74 A LYS 75 n 75 LYS 75 A MET 76 n 76 MET 76 A LYS 77 n 77 LYS 77 A ASP 78 n 78 ASP 78 A THR 79 n 79 THR 79 A ASP 80 n 80 ASP 80 A SER 81 n 81 SER 81 A GLU 82 n 82 GLU 82 A GLU 83 n 83 GLU 83 A GLU 84 n 84 GLU 84 A ILE 85 n 85 ILE 85 A ARG 86 n 86 ARG 86 A GLU 87 n 87 GLU 87 A ALA 88 n 88 ALA 88 A PHE 89 n 89 PHE 89 A ARG 90 n 90 ARG 90 A VAL 91 n 91 VAL 91 A PHE 92 n 92 PHE 92 A ASP 93 n 93 ASP 93 A LYS 94 n 94 LYS 94 A ASP 95 n 95 ASP 95 A GLY 96 n 96 GLY 96 A ASN 97 n 97 ASN 97 A GLY 98 n 98 GLY 98 A TYR 99 n 99 TYR 99 A ILE 100 n 100 ILE 100 A SER 101 n 101 SER 101 A ALA 102 n 102 ALA 102 A ALA 103 n 103 ALA 103 A GLU 104 n 104 GLU 104 A LEU 105 n 105 LEU 105 A ARG 106 n 106 ARG 106 A HIS 107 n 107 HIS 107 A VAL 108 n 108 VAL 108 A MET 109 n 109 MET 109 A THR 110 n 110 THR 110 A ASN 111 n 111 ASN 111 A LEU 112 n 112 LEU 112 A GLY 113 n 113 GLY 113 A GLU 114 n 114 GLU 114 A LYS 115 n 115 LYS 115 A LEU 116 n 116 LEU 116 A THR 117 n 117 THR 117 A ASP 118 n 118 ASP 118 A GLU 119 n 119 GLU 119 A GLU 120 n 120 GLU 120 A VAL 121 n 121 VAL 121 A ASP 122 n 122 ASP 122 A GLU 123 n 123 GLU 123 A MET 124 n 124 MET 124 A ILE 125 n 125 ILE 125 A ARG 126 n 126 ARG 126 A GLU 127 n 127 GLU 127 A ALA 128 n 128 ALA 128 A ASP 129 n 129 ASP 129 A ILE 130 n 130 ILE 130 A ASP 131 n 131 ASP 131 A GLY 132 n 132 GLY 132 A ASP 133 n 133 ASP 133 A GLY 134 n 134 GLY 134 A GLN 135 n 135 GLN 135 A VAL 136 n 136 VAL 136 A ASN 137 n 137 ASN 137 A TYR 138 n 138 TYR 138 A GLU 139 n 139 GLU 139 A GLU 140 n 140 GLU 140 A PHE 141 n 141 PHE 141 A VAL 142 n 142 VAL 142 A GLN 143 n 143 GLN 143 A MET 144 n 144 MET 144 A MET 145 n 145 MET 145 A THR 146 n 146 THR 146 A ALA 147 n 147 ALA 147 A LYS 148 n 148 LYS 148 A LYS 149 n 1 LYS 149 B LYS 150 n 2 LYS 150 B THR 151 n 3 THR 151 B PHE 152 n 4 PHE 152 B LYS 153 n 5 LYS 153 B GLU 154 n 6 GLU 154 B VAL 155 n 7 VAL 155 B ALA 156 n 8 ALA 156 B ASN 157 n 9 ASN 157 B ALA 158 n 10 ALA 158 B VAL 159 n 11 VAL 159 B LYS 160 n 12 LYS 160 B ILE 161 n 13 ILE 161 B SER 162 n 14 SER 162 B ALA 163 n 15 ALA 163 B SER 164 n 16 SER 164 B LEU 165 n 17 LEU 165 B author_defined_assembly 2 dimeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N ILE 100 A N ILE 100 A O VAL 136 A O VAL 136 1 A A O H VAL MET 121 124 1.58 2 A A O H ILE LYS 9 13 1.51 7 A A O H VAL MET 121 124 1.55 11 A A O HG21 ASP VAL 118 121 1.52 14 A A O H VAL MET 121 124 1.47 14 A A O HG23 ASP VAL 118 121 1.59 1 A ASP 56 36.94 70.00 1 A THR 79 -149.40 -100.26 1 A ASP 80 -177.03 104.92 1 A ASP 122 -43.72 -18.65 1 B LYS 150 -150.86 -41.71 1 B THR 151 -153.36 -53.99 2 A ASP 56 28.45 69.22 2 A THR 79 56.62 -57.98 2 A ASP 118 -47.31 -16.67 2 A ASN 137 -110.00 -165.89 2 B LYS 150 79.29 50.57 2 B THR 151 -154.51 -62.09 2 B PHE 152 -153.88 -31.67 2 B SER 164 -95.50 31.72 3 A ASP 2 62.97 126.44 3 A ASP 56 36.80 70.83 3 A THR 79 -149.14 -106.14 3 A ASP 80 -160.27 99.22 3 A LYS 115 -68.96 -136.46 3 A LEU 116 -31.46 132.91 3 A ARG 126 -47.14 -14.95 3 A ALA 147 -105.22 76.18 3 B LYS 150 -149.16 -39.84 3 B THR 151 -157.23 -49.54 4 A ASP 2 63.62 131.57 4 A ARG 37 -45.76 -19.76 4 A GLN 41 -175.35 127.14 4 A ASN 42 -130.04 -53.21 4 A ASP 56 35.92 69.82 4 A THR 79 -147.73 -96.67 4 A ASP 80 -176.69 105.39 4 A LYS 115 -54.53 -138.34 4 A LEU 116 -40.30 166.71 4 A ASP 118 -40.08 -17.75 4 A ASP 129 -61.63 93.59 4 B LYS 150 -156.21 -37.33 5 A GLU 6 -49.78 -17.48 5 A THR 79 -142.53 -104.50 5 A LYS 115 -75.11 -137.01 5 A LEU 116 -33.95 145.39 5 A ASP 118 -38.64 -16.85 5 A ALA 128 -149.46 44.18 5 A ASP 129 -59.62 103.63 5 A ALA 147 -104.29 74.43 5 B THR 151 89.28 -33.29 5 B PHE 152 -173.88 22.44 6 A ASP 56 26.31 69.54 6 A ASP 64 -119.69 -162.06 6 A THR 79 -157.29 -108.61 6 A ASP 80 -167.59 101.53 6 A ALA 147 -103.00 78.46 6 B LYS 150 -156.07 -36.42 7 A THR 79 -151.87 -106.99 7 A ASP 80 -168.64 100.40 7 A LYS 115 -68.33 -136.51 7 A LEU 116 -36.58 133.29 7 A ASP 118 -39.53 -16.50 7 A ASP 122 -40.58 -19.22 7 B LYS 150 -150.33 -36.99 8 A ASP 56 31.67 70.40 8 A THR 79 -39.55 100.09 8 A ASP 80 172.18 33.48 8 A ASN 111 -58.86 -4.31 8 A ASP 118 -49.10 -17.36 8 A ASP 129 -67.65 79.23 8 B LYS 150 -152.82 -37.29 8 B ALA 163 52.42 14.04 9 A GLU 6 -48.85 -17.57 9 A ASP 56 33.97 69.98 9 A THR 79 -153.17 -111.50 9 A ASP 80 -160.86 100.05 9 A LYS 115 -67.17 -136.95 9 A LEU 116 -32.98 133.32 9 A ASP 118 -41.05 -17.46 9 B LYS 150 -156.19 -31.50 10 A ASP 2 64.00 138.89 10 A GLU 6 -49.08 -17.47 10 A ASP 64 -100.75 -161.03 10 A THR 79 -148.98 -86.27 10 A ASP 80 -176.38 107.98 10 A ASP 118 -39.84 -23.32 10 A ALA 128 -168.42 53.70 10 A ALA 147 -113.73 78.29 10 B PHE 152 116.94 -4.70 10 B LYS 153 -145.54 -30.25 11 A ASP 64 -89.31 -153.61 11 A THR 79 -151.28 -106.52 11 A ASP 80 -172.04 102.44 11 A LYS 115 -66.34 -135.58 11 A LEU 116 -29.50 132.69 11 A ASP 129 -68.11 79.25 11 B LYS 150 -170.48 26.64 11 B THR 151 -148.53 -35.98 12 A GLN 41 -174.94 126.53 12 A ASN 42 -152.90 -60.79 12 A ASP 56 23.51 68.94 12 A THR 79 -148.91 -102.09 12 A ASP 80 -174.47 103.40 12 A LYS 115 -72.16 -136.03 12 A LEU 116 -37.02 153.51 12 A ASP 118 -40.26 -17.74 12 A ASP 129 -69.15 94.28 12 B PHE 152 -142.46 10.11 13 A GLU 6 -48.85 -17.54 13 A VAL 55 -130.28 -31.34 13 A ASP 56 45.86 71.67 13 A ASP 78 -89.29 30.44 13 A THR 79 -148.74 -34.70 13 A ASP 80 81.71 111.12 13 A LYS 115 -67.75 -136.78 13 A ASP 118 -39.95 -16.63 13 A ALA 147 -105.83 79.88 13 B THR 151 -142.80 -39.21 14 A GLU 6 -49.81 -17.86 14 A ASP 56 30.78 69.39 14 A ASP 64 -109.69 -165.25 14 A THR 79 -148.80 -101.56 14 A ASP 80 -176.16 105.64 14 A LYS 115 -67.60 -136.65 14 A LEU 116 -38.40 132.81 14 A ASP 122 -41.83 -19.82 14 B LYS 150 -151.81 -44.59 14 B THR 151 -141.81 -44.64 15 A GLU 6 -48.97 -17.69 15 A ASP 56 32.51 69.44 15 A THR 79 -149.66 -102.54 15 A ASP 80 -174.01 105.32 15 A ASP 122 -48.89 -18.13 15 A ASP 129 -67.37 87.55 15 A ALA 147 -90.23 48.86 15 B LYS 150 -159.36 18.30 15 B THR 151 -152.51 -45.17 16 A GLU 6 -49.47 -17.48 16 A ASP 56 30.24 68.00 16 A ASP 64 -103.35 -161.74 16 A THR 79 -152.86 -111.63 16 A ASP 80 -162.78 100.60 16 A ASP 122 -44.75 -18.57 16 A ASP 129 -69.42 85.46 16 B LYS 150 -151.89 -34.49 17 A ASP 56 23.05 69.22 17 A THR 79 -149.38 -111.71 17 A ASP 80 -179.72 105.51 17 A LYS 115 -70.39 -135.51 17 A LEU 116 -27.97 133.40 17 A ASP 118 -37.87 -20.70 17 A ASP 129 -65.98 98.46 17 A ALA 147 -94.47 30.29 17 B LYS 150 -163.13 -36.21 18 A GLU 6 -49.51 -17.67 18 A THR 79 -152.42 -114.15 18 A LYS 115 -66.96 -136.49 18 A LEU 116 -33.78 132.58 18 A ASP 118 -44.50 -17.21 18 B LYS 150 79.88 -10.61 19 A GLU 6 -48.50 -17.63 19 A THR 79 -151.10 -110.77 19 A ASP 80 -163.85 100.99 19 A LYS 115 -66.62 -136.64 19 A ASP 122 -41.15 -17.65 19 A ASN 137 -114.87 -164.84 19 B LYS 150 -141.96 -59.44 19 B THR 151 -154.16 -31.37 20 A GLU 6 -49.80 -17.24 20 A ASP 56 34.36 69.93 20 A THR 79 -150.26 -107.73 20 A ASP 93 -56.07 100.81 20 A LYS 115 -72.41 -135.81 20 A LEU 116 -28.04 132.91 20 A ASP 118 -36.97 -19.03 20 A ASP 122 -48.05 -17.87 20 A ALA 128 -153.07 42.52 20 B LYS 150 -169.35 -30.33 lowest energy, model 1 Solution NMR structure of CaM bound to the eNOS CaM binding domain peptide 1 N N 2 N N A THR 5 A THR 5 HELX_P A GLU 14 A GLU 14 1 1 10 A ALA 15 A ALA 15 HELX_P A ASP 20 A ASP 20 1 2 6 A GLU 31 A GLU 31 HELX_P A GLY 40 A GLY 40 1 3 10 A THR 44 A THR 44 HELX_P A ASP 50 A ASP 50 1 4 7 A ASP 64 A ASP 64 HELX_P A LEU 69 A LEU 69 1 5 6 A LEU 69 A LEU 69 HELX_P A ARG 74 A ARG 74 1 6 6 A SER 81 A SER 81 HELX_P A ARG 86 A ARG 86 1 7 6 A ARG 86 A ARG 86 HELX_P A ASP 93 A ASP 93 1 8 8 A ALA 102 A ALA 102 HELX_P A THR 110 A THR 110 1 9 9 A ASN 111 A ASN 111 HELX_P A GLY 113 A GLY 113 5 10 3 A GLU 119 A GLU 119 HELX_P A ALA 128 A ALA 128 5 11 10 A ASN 137 A ASN 137 HELX_P A MET 145 A MET 145 1 12 9 B PHE 152 B PHE 4 HELX_P B SER 162 B SER 14 1 13 11 OXIDOREDUCTASE OXIDOREDUCTASE CALM_HUMAN UNP 1 2 P62158 ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTD SEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAK NOS3_HUMAN UNP 2 493 P29474 KKTFKEVANAVKISASL 2 149 2LL7 1 148 P62158 A 1 1 148 493 509 2LL7 149 165 P29474 B 2 1 17 2 anti-parallel A ILE 100 A ILE 100 A SER 101 A SER 101 A GLN 135 A GLN 135 A VAL 136 A VAL 136